Cholestasis and congenital neuroblastoma in a preterm neonate: a case report
2022

Cholestasis and congenital neuroblastoma in a preterm neonate

Sample size: 1 publication Evidence: low

Author Information

Author(s): Puvabanditsin Surasak, Guillermo Melissa, Cheng Yisha, Sudol Olga, Mehta Rajeev

Primary Institution: Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

Conclusion

This case report presents the first known instance of metastatic neuroblastoma in a preterm neonate that manifested as cholestasis without an identifiable primary site.

Supporting Evidence

  • Neuroblastoma is one of the most common tumors during the perinatal period.
  • Congenital neuroblastomas are often detected incidentally during prenatal care.
  • The infant developed cholestasis, which led to the diagnosis of stage MS neuroblastoma.

Takeaway

A baby born early developed a liver problem that turned out to be a rare type of cancer called neuroblastoma, which usually doesn't show up like this.

Methodology

The case report includes clinical presentation, diagnostic imaging, and treatment details of a preterm neonate diagnosed with neuroblastoma.

Limitations

The study is based on a single case report, limiting the generalizability of the findings.

Participant Demographics

A 24-day old male preterm neonate born at 32 weeks gestation.

Digital Object Identifier (DOI)

10.1515/crpm-2021-0089

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication